Skip to main content
. 2021 Apr 26;49(4):03000605211004039. doi: 10.1177/03000605211004039

Figure 1.

Figure 1.

IL-30 levels in patients with psoriasis and healthy controls. (a) Flow diagram of the study. (b). A comparison of the serum IL-30 levels in the psoriatic (N=26) and control groups (N=26) determined using an enzyme-linked immunosorbent assay kit. The results are shown as the mean ± standard deviation. ***p<0.001 by Student’s t-test. (c) Spearman’s correlation analysis of IL-30 levels and PASI scores in patients with psoriasis

IL-30, interleukin-30; PASI, Psoriasis Severity and Area Index.